Yokoyama Laboratory for Molecular Biology of Stem Cell
Publication in 2022
| 1 | Ku, C-C., Wuputra, K., Pan, J-B., Li C-P., Liu, C-J., Liu, Y-C., Saito, S., Chan, T- F., Lin, C.S., Wu, D-C.*, and Yokoyama, K.*: Cancer signaling from induced pluripotent stem cell-derived organoids induced by Helicobacter Pylori infection. Cells, 11, 184. https://doi.org/10.3390/cells11020184 (2022). |
| 2 | Saito, S., Ku, C-C., Wuputra, K., Pan, J-B., Lin, C-S., Lin, Y-C., Wu, D-C., and Yokoyama, K.*: Biomarkers of cancer stem cells for experimental research and clinical application. Journal of Personalized Medicine 12, 715. doi: 10.3390/jpm12050715 (2022). |
| 3 | Wuputra, K., Ku, C-C., Pan, J-B., Liu, C-J., Liu, Y-C., Saito, S., Kato, K., Lin, Y-C., Kuo, K-K., Chan, T-F., Chong, I-W., Lin, C-S., Wu, D-C., Yokoyama, K.*: Stem cell biomarkers and tumorigenesis in gastric cancer. Journal of Personalized Medicine, 12, 929 https://doi.org/10.3390/jpm12060929 (2022). |
| 4 | Wuputra, K., Hsiao P-J., Chang, W.T., Wu, P-H., Chen, L-A., Huang, J-W., Su, W-L., Yang, Y-H., Wu, D-C., Yokoyama, K.* and Kuo, K-K*. FOXM1-CD44 signaling is critical or the acquisition of regorafenib resistance in human liver cancer cells. International Journal of Molecular Sciences, 23, 7782. doi: 10.3390/ijms23147782. (2022). |
Kaohsiung Medical University
Graduate Institute of Medicine100 shih-Chuan 1st Road, San Ming District, Kaohsiung, 80708, Taiwan